Transaction #23113 · Form 4 · 0002156015-26-000005
Iambic Therapeutics, Inc. · Stock award · Common Stock
Iambic Therapeutics, Inc. · Transacted October 14, 2026 · Filed October 16, 2026
What does this filing report?
An SEC Form 4 filing for Iambic Therapeutics, Inc. records a stock award involving Common Stock on October 14, 2026. The reported quantity was 132,200. The filing date is October 16, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Iambic Therapeutics, Inc.
- Company CIK
- 0001997038
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 132,200
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,862,665
- Ownership description
- Not reported
- SEC acceptance time
- Oct 16, 2026, 4:09 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Manby Frederick R ↗
Chief Technology Officer · Director
CIK 0002156015
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The reported shares are represented by restricted stock units, or RSUs, which vest as follows: 25% of the RSUs vest on September 10, 2027 and the remaining RSUs vest in twelve equal quarterly installments beginning on December 10, 2027.
- F2
- Twenty-five percent of the shares subject to the option vest on October 14, 2027 and 1/48th of the shares vest monthly thereafter.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.